Ligand Pharmaceuticals IncorporatedLigand Pharmaceuticals IncorporatedLigand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated

No trades
See on Supercharts

LGND fundamentals

Ligand Pharmaceuticals Incorporated financial statements, including revenue, expenses, profit, and loss

The total revenue of LGND for the last quarter is 30.98 M USD, and it's 10.24% higher compared to the previous quarter. The net income of Q1 24 is 86.14 M USD.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth